Rankings
▼
Calendar
HOWL Q1 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.43
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$57,000
Balance Sheet
Total Assets
$0
Total Liabilities
-$10M
Stockholders' Equity
$10M
Cash & Equivalents
$0
← FY 2020
All Quarters
Q2 2020 →
